[A specialist nurse consultation for post-transplant follow-up of patients undergoing allogeneic hematopoietic cell transplantation: Recommendations of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Mise en place d’une consultation infirmière de suivi post-allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 28 01 2019
revised: 17 06 2019
accepted: 17 06 2019
pubmed: 11 9 2019
medline: 4 3 2020
entrez: 11 9 2019
Statut: ppublish

Résumé

The number of hematopoietic stem cell transplantation is in constant rise. This increase has put in spotlight the lack of physician availability. Some healthcare centers have already organised a nurse's consultation under the supervision of an expert physician. We conducted a survey among nurses and physicians from the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) centers who confirmed the need to create a special transplantation-skilled population of nurses. During this ninth annual workshop of the SFGM-TC, we have defined the required conditions for a transplant nurse consultation until day 100 post-transplant with the responsibility of the transplant expert physician. To help the centers in this dynamic, we provided practical tools to support this consultation. The current heath policy is in favor of an increased autonomy of the expert nurse. The implementation of the status of nurse in advanced practice is the first step in this professional development.

Identifiants

pubmed: 31500804
pii: S0007-4551(19)30240-1
doi: 10.1016/j.bulcan.2019.06.002
pii:
doi:

Types de publication

Consensus Development Conference Journal Article Practice Guideline

Langues

fre

Sous-ensembles de citation

IM

Pagination

S68-S71

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

Fabienne Colledani (F)

Hôpital Saint-Louis, service d'hématologie-greffe, 1, avenue Claude-Vellefaux, 75475 Paris cedex 10, France. Electronic address: fabienne.colledani@aphp.fr.

Sandrine Barrault (S)

Institut de cancérologie de la Loire-Lucien-Neuwirth, hôpital de jour d'hématologie greffe, 108, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France.

Caroline Bayle (C)

CHU d'Angers, maladies du sang, 4, rue Larrey, 49035 Angers cedex, France.

Aurélie Debray (A)

CHU de Rennes, service d'onco-hématologie, 16, boulevard de Bulgarie, 35203 Rennes, France.

Virginie Denis (V)

CHRU de Rouen, service d'onco-hémato-immunologie pédiatrique, 1, rue de Germont, 76000 Rouen, France.

Ghislaine François (G)

CHU de Nantes, Hôtel-Dieu, service d'hématologie adulte, 1, place Alexis-Ricordeau, 44000 Nantes, France.

Séverine Hie (S)

CHRU de Lille, maladies du sang, rue Michel Polonowski, 59037 Lille cedex, France.

Nadège Hounmenou (N)

CHU d'Angers, maladies du Sang/Unité Harvey: pôle Hippocrate, 4, rue Larrey, 49933 Angers cedex 9, France.

Thomas Jezequel (T)

CHU de Nantes, hôpital enfant-adolescent, service onco-hématologie pédiatrique, quai Moncousu, 5(e) étage, 44093 Nantes cedex 1, France.

Laetitia Le Bars (L)

CHU de Rennes, service d'hématologie adulte, avenue Henri-Le-Guilloux, 35000 Rennes, France.

Natacha Lepage (N)

Cliniques universitaires Saint Luc, service d'hématologie, avenue Hippocrate, 10, 1200 Bruxelles, Belgique.

Sophie Porcheron (S)

CLCC Henri-Becquerel, service d'hématologie, 1, rue d'Amiens, 76038 Rouen cedex, France.

Stéphanie Schmitt (S)

CHRU de Strasbourg, unité de greffe de moelle osseuse, 1, avenue Molière, 69098 Strasbourg cedex, France.

Ibrahim Yakoub-Agha (I)

CHU de Lille, université de Lille, LIRIC, Inserm U995, 59000 Lille, France.

Valérie Coiteux (V)

CHRU de Lille, hôpital Huriez, service maladies du sang, secteur Allogreffe de CSH, rue Michel-olonowski, 59037 Lille cedex, France. Electronic address: valerie.coiteux@chru-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH